alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
IB 

Union Calendar No. 486 

118TH CONGRESS 

2D SESSION H. R. 7280 

[Report No. 118–586] 

To require the Inspector General of the Department of Housing and Urban 

Development to testify before the Congress annually, and for other purposes. 

IN THE HOUSE OF REPRESENTATIVES 

FEBRUARY 7, 2024 

Ms. DE LA CRUZ (for herself, Mr. BARR, Mr. OGLES, Mr. DONALDS, Mr. 

LAWLER, Mr. CRENSHAW, Mr. FLOOD, Mr. MEUSER, Mr. HUIZENGA, 

Mr. ROSE, Mr. NORMAN, Mr. WEBER of Texas, Mr. MCCAUL, Mr. 

POSEY, Mr. LOUDERMILK, Mr. WILLIAMS of Texas, Ms. HAGEMAN, Mrs. 

WAGNER, and Ms. PORTER) introduced the following bill; which was referred to the Committee on Financial Services 

JULY 15, 2024 

Additional sponsors: Mrs. HOUCHIN, Mr. MOONEY, Mr. LALOTA, Mr. 

WILLIAMS of New York, and Mr. EMMER

JULY 15, 2024 

Reported with an amendment, committed to the Committee of the Whole 

House on the State of the Union, and ordered to be printed 

[Strike out all after the enacting clause and insert the part printed in italic] 

[For text of introduced bill, see copy of bill as introduced on February 7, 2024] 


ssavage on LAPJG3WLY3PROD with BILLS
2 

•HR 7280 RH

A BILL 

To require the Inspector General of the Department of Housing and Urban Development to testify before the Congress annually, and for other purposes. 


ssavage on LAPJG3WLY3PROD with BILLS
3 

•HR 7280 RH

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. SHORT TITLE. 

4 This Act may be cited as the ‘‘HUD Transparency Act 

5 of 2024’’. 

6 SEC. 2. CONGRESSIONAL TESTIMONY. 

7 Not later than October 1 of each year, the Inspector 

8 General of the Department of Housing and Urban Develop9 ment shall appear before the Committee on Financial Serv10 ices of the House of Representatives and the Committee on 

11 Banking, Housing, and Urban Affairs of the Senate and 

12 present testimony on the Office of Inspector General’s— 

13 (1) efforts to detect and prevent fraud, waste, 

14 and abuse; 

15 (2) ability to conduct and supervise audits, in16 vestigations, and reviews; 

17 (3) actions to identify opportunities for the pro18 grams of the Department of Housing and Urban De19 velopment to progress and succeed; 

20 (4) recommendations to improve overall effi21 ciency and public accountability; 

22 (5) assessment of the extent to which the Depart23 ment of Housing and Urban Development has re24 sources sufficient to carry out its statutory mission; 

25 and 


ssavage on LAPJG3WLY3PROD with BILLS
4 

•HR 7280 RH

1 (6) ongoing activities regarding any such addi2 tional work, as appropriate. 


ssavage on LAPJG3WLY3PROD with BILLS

ssavage on LAPJG3WLY3PROD with BILLS
Union Calendar No. 486 

118TH CONGRESS 

2D SESSION H. R. 7280 

[Report No. 118–586] 

A BILL 

To require the Inspector General of the Departpurposes. tify before the Congress annually, and for other ment of Housing and Urban Development to tesJULY 15, 2024 Reported with an amendment, committed to the Comand ordered to be printed mittee of the Whole House on the State of the Union, 


ssavage on LAPJG3WLY3PROD with BILLS
§ 520.1806 Piperazine suspension. ( a ) *Specifications.* Each milliliter of suspension contains piperazine monohydrochloride equivalent to 33.5 milligrams (mg) piperazine base.
( b ) *Sponsor.* See No. 017135 in § 510.600(c) of this chapter.
( c ) *Special considerations.* See § 500.25(c) of this chapter.
( d ) *Conditions of use in dogs* — ( 1 ) *Indications for use.* For the removal of roundworms (*Toxocara canis*and *Toxascaris leonina*).
( 2 ) *Dosage.* Administer 20 to 30 mg piperazine base per pound body weight as a single dose.
( 3 ) *Limitations.* Administer by mixing into the animal's ration to be consumed at one feeding. For animals in heavily contaminated areas, reworm at monthly intervals. Not for use in unweaned pups or animals less than 3 weeks of age.
[70 FR 17319, Apr. 6, 2005]
EXHIBIT 32.1

                CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,
                    AS ADOPTED PURSUANT TO SECTION 906 OF THE
                           SARBANES-OXLEY ACT OF 2002

     In connection with the quarterly report of Avitar,  Inc. (the "Company") on
Form10-QSB  for the period ending June 30, 2006 as filed with the Securities and
Exchange  Commission on the date hereof (the  "Report"),  I, Peter P.  Phildius,
Chief Executive  Officer of the Company certify,  pursuant to 18 U.S.C.  Section
1350, as adopted pursuant to Section 906 of the  Sarbanes-Oxley  Act of 2002, to
my knowledge, that:

     (1) The Report  fully  complies  with the  requirements  of  Section  13(a)
or15(d) of the Securities Exchange Act of 1934; and

     (2)  The  information  contained  in the  Report  fairly  presents,  in all
material  respects,  the  financial  condition  and results of operations of the
Company.

Date: August 14, 2006

                                                 /s/ Peter P. Phildius
                                                 ---------------------
                                                 Peter P. Phildius Chief
                                                 Executive Officer
§ 522.2002 Propiopromazine. ( a ) *Specifications.* Each milliliter of solution contains 5 or 10 milligrams (mg) propiopromazine hydrochloride.
( b ) *Sponsor.* See No. 054771 in § 510.600(c) of this chapter.
( c ) *Conditions of use in dogs and cats* — ( 1 ) *Amounts and indications for use.* Administer 0.05 to 0.5 mg per pound of body weight by intravenous or intramuscular injection for tranquilization. Administer 0.25 mg per pound of body weight by intravenous injection as a preanesthetic.
( 2 ) *Limitations.* Federal law restricts this drug to use by or on the order of a licensed veterinarian.
[79 FR 16195, Mar. 25, 2014]
**Exhibit31.1**

 

CERTIFICATIONS

 

I, Carl Mostert, certify that

 

1. I have reviewed this quarterly report on Form 10-Q of SpescomSoftware Inc.;

 

2. Based on my knowledge, this quarterly report does not contain anyuntrue statement of a material fact or omit to state a material fact necessaryto make the statements made, in light of the circumstances under which suchstatements were made, not misleading with respect to the period covered by thisquarterly report;

 

3. Based on my knowledge, the financial statements, and other financialinformation included in this quarterly report, fairly present in all materialrespects the financial condition, results of operations and cash flows of theregistrant as of, and for, the periods presented in this quarterly report;

 

4. The registrant’s other certifying officers and I are responsible forestablishing and maintaining disclosure controls and procedures (as defined inExchange Act Rules 13a-14 and 15d-14) for the registrant and have:

 

a) designed such disclosure controls and procedures to ensure thatmaterial information relating to the registrant, including its consolidatedsubsidiaries, is made known to us by others within those entities, particularlyduring the period in which this quarterly report is being prepared;

 

b) evaluated the effectiveness of the registrant’s disclosure controlsand procedures as of a date within 90 days prior to the filing date of thisquarterly report (the “Evaluation Date”); and

 

c) Presented in this quarterly report our conclusions about theeffectiveness of the disclosure controls and procedures based on our evaluationas of the Evaluation Date;

 

5. The registrant’s other certifying officers and I have disclosed,based on our most recent evaluation, to the registrant’s auditors and the auditcommittee of registrant’s board of directors (or persons performing theequivalent functions):

 

a) all significant deficiencies in the design or operation of internalcontrols which could adversely affect the registrant’s ability to record,process, summarize and report financial data and have identified for theregistrant’s auditors any material weaknesses in internal controls; and

 

b) any fraud, whether or not material, that involves management orother employees who have a significant role in the registrant’s internalcontrols; and

 

6. The registrant’s other certifying officers and I have indicated inthis quarterly report whether there were significant changes in internalcontrols or in other factors that could significantly affect internal controlssubsequent to the date of our most recent evaluation, including any correctiveactions with regard to significant deficiencies and material weaknesses.

 

 
| Dated:  February 13, 2004 |
|-------------------------------------|
|                                |
| /s/ Carl Mostert                    |   |
| Carl Mostert                        |
|                                |
| Chief Executive Officer             |

 

----
[No. 40021-5-I.

Division One.

January 26, 1998.]

#### The State of Washington, *Respondent,*v. Samuel Dorsey, *Appellant.*

Appeal from a judgment of the Superior Court for King County, No. 95-1-02145-6, JoAnne Alumbaugh, J., entered January 9, 1998. *Affirmed*by unpublished per curiam opinion.
**Exhibit 31.1**

 

# **CERTIFICATION**

# ** **

I, Terrence J. Scully, certify that:

 

1.     I have reviewed this annualreport on Form 10-K, and all reports on Form 8-K containing distribution orservicing reports filed in respect of periods included in the year covered bythis annual report, of Target Credit Card Master Trust;

 

# **2.     Based on my knowledge, the information inthese reports, taken as a whole, does not contain any untrue statement of amaterial fact or omit to state a material fact necessary to make the statementsmade, in light of the circumstances under which such statements were made, notmisleading as of the last day of the period covered by this annual report;**

# ** **

3.     Based on my knowledge, thedistribution or servicing information required to be provided to the trustee bythe servicer under the pooling and servicing, or similar, agreement, forinclusion in these reports is included in these reports;

 

4.     I am responsible forreviewing the activities performed by the servicer under the pooling andservicing, or similar, agreement and based upon my knowledge and the annualcompliance review required under that agreement, and except as disclosed in thereports, the servicer has fulfilled its obligations under that agreement; and

 

5.     The reports disclose allsignificant deficiencies relating to the servicer’s compliance with the minimumservicing standards based upon the report provided by an independent publicaccountant, after conducting a review in compliance with the Uniform SingleAttestation Program for Mortgage Bankers or similar procedure, as set forth inthe pooling and servicing, or similar, agreement, that is included in thesereports.

 

 
| Dated: March 31, 2006 | By:                            | /s/ Terrence J. Scully |   |
|-----------------------|--------------------------------|------------------------|--------|
|                  | Terrence J. Scully,            |
|                  | Vice President and Director    |
|                  | Target Receivables Corporation |

 

----
<TABLE> <S> <C>

<ARTICLE> 5
       
<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-1998
<PERIOD-START>                             JAN-01-1998
<PERIOD-END>                               SEP-30-1998
<CASH>                                         764,674
<SECURITIES>                                         0
<RECEIVABLES>                                   92,269
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                                     0
<PP&E>                                      11,096,145
<DEPRECIATION>                               4,360,202
<TOTAL-ASSETS>                              13,185,873
<CURRENT-LIABILITIES>                       11,568,900
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                             0
<OTHER-SE>                                   1,616,973
<TOTAL-LIABILITY-AND-EQUITY>                13,185,873
<SALES>                                      3,635,599
<TOTAL-REVENUES>                             3,635,599
<CGS>                                                0
<TOTAL-COSTS>                                        0
<OTHER-EXPENSES>                             3,349,196
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                             693,834
<INCOME-PRETAX>                              (454,999)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                                  0
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                 (454,999)
<EPS-PRIMARY>                                        0
<EPS-DILUTED>                                        0
        

</TABLE>
#### Reed *v.*First National Bank of Corning.

Opinion delivered December 8, 1919.

Judgment — conformity to pleading.- — In an action to enforce a vendor’s lien upon land, a complaint in which the only reference to a certain defendant was an allégation that such defendant claims an interest in the land was insufficient to sustain a decree by default against such defendant for repovery of the purchase money.

Appeal from Clay Chancery Court, Western District; *Archer*Wheatley, Chancellor;

reversed.

*C. T. Bloodworth,*for appellant.

It was error to render a personal judgment against appellant, as no liability is shown by the evidence or alleged in the complaint that he owed any part of the consideration for the property. 73 Ark. 221. The complaint *112states no cause of action against Reed, the appellant. 8 Ark. 456; *lb.*484 ; 25 *Id.*570; 66 *Id.*113; 74 *Id.*468; 89 *Id.*117; 107 *Id.*353.

McCulloch;, C. J.

' Appellee instituted this action in the chancery court of Clay County (Western District) against appellant and one Brown to foreclose a lien on certain real estate for the purchase price. It was alleged in the complaint that J. E. Matthews sold the real estate in question to Brown and that Brown executed to Matthews the promissory notes in suit, which were assigned to appellee by Matthews. The only reference in the complaint to appellant was as follows:

> “That plaintiff understands that the defendant, Ernest Reed, is claiming some interest or claim on said lot.”

The notes were exhibited with the complaint. Appellant and Brown were'both served with summons to appear in the action, but neither appeared, and there was a default decree against both of them, which was for the recovery of the amount of the notes ($740.80) and for foreclosure of the vendor’s lien on the real estate conveyed by Matthews to Brown. Appellant has prosecuted an appeal from the personal decree against him for recovery of the amount of the notes.

The decree was obviously wrong to the extent that it was for the recovery of the amount of the notes from appellant personally. The complaint contained no allegation which would be sufficient to warrant such a decree. The only allegation was that he was claiming some interest in the lot sold by Matthews to Brown. This feature of the decree may have been an inadvertence or misprision of the clerk in entering the decree, but as the decree stands upon the record it is erroneous and appellant is entitled to a reversal to that extent.
I 

118TH CONGRESS 

1ST SESSION H. R. 746 

To amend title 38, United States Code, to expand certain rehabilitation 

programs for certain veterans with service-connected disabilities. 

IN THE HOUSE OF REPRESENTATIVES 

FEBRUARY 2, 2023 

Mr. OBERNOLTE (for himself and Mr. NEGUSE) introduced the following bill; 

which was referred to the Committee on Veterans’ Affairs 

A BILL 

To amend title 38, United States Code, to expand certain 

rehabilitation programs for certain veterans with serviceconnected disabilities. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. SHORT TITLE. 

4 This Act may be cited as the ‘‘Streamlining Aviation 

5 for Eligible Veterans Act’’ or the ‘‘SAFE Veterans Act’’. 


kjohnson on DSK79L0C42PROD with BILLS
2 

•HR 746 IH

1 SEC. 2. INCLUSION OF NON-DEGREE FLIGHT TRAINING IN 

2 CERTAIN REHABILITATION PROGRAMS FOR 

3 CERTAIN VETERANS WITH SERVICE-CON4 NECTED DISABILITIES. 

5 Section 3101 of title 38, United States Code, is 

6 amended in paragraph (6) by adding at the end the fol7 lowing: ‘‘A rehabilitation program may include a program 

8 that includes flight training and does not lead to a de9 gree.’’. 

Æ 


kjohnson on DSK79L0C42PROD with BILLS
#### § 558.185 Coumaphos.

(a) *Specifications.* Type A medicated articles containing 1.12, 2.0, 11.2, or 50 percent coumaphos.

(b) *Sponsor.* See No. 058198 in [§ 510.600(c) of this chapter](/on/2024-09-17/title-21/section-510.600#p-510.600(c)).

(c) *Related tolerances.* See [§ 556.168 of this chapter](/on/2024-09-17/title-21/section-556.168).

(d) *Special considerations.*

(1) Labeling shall bear the following warning: The active ingredient coumaphos is a cholinesterase inhibitor. Do not use this product on animals simultaneously or within a few days before or after treatment with, or exposure to, cholinesterase-inhibiting drugs, pesticides, or chemicals.

(2) See [§ 500.25 of this chapter](/on/2024-09-17/title-21/section-500.25).

(e) *Conditions of use in laying chickens.*

| Coumaphos in grams per ton | Indications for use | Limitations | Sponsor |
| --- | --- | --- | --- |
| (1) 27.2 (0.003 percent) | Laying chickens: For control of capillary worm (*Capillaria obsignata*) and as an aid in control of common round worm (*Ascaridia galli*) and cecal worm (*Heterakis gallinae*) | Feed continuously as the sole ration for 14 days. If reinfection occurs, treatment may be repeated, but not sooner than 3 weeks after the end of the previous treatment. Do not feed to chickens within 10 days of vaccination or other conditions of stress. | 058198 |
| (2) 36.3 (0.004 percent) | Replacement pullets: For control of capillary worm (*Capillaria obsignata*) and as an aid in control of common round worm (*Ascaridia galli*) and cecal worm (*Heterakis gallinae*) | Feed continuously as the sole ration for from 10 to 14 days. Do not feed to chickens under 8 weeks of age or within 10 days of vaccination or other conditions of stress. If birds are maintained on contaminated litter or exposed to infected birds, a second 10- to 14-day treatment is recommended, but not sooner than 3 weeks after the end of the previous treatment. If reinfection occurs after production begins, repeat treatment as recommended for laying flocks. | 058198 |

[[86 FR 14822](https://www.federalregister.gov/citation/86-FR-14822), Mar. 19, 2021]
<TABLE> <S> <C>

<ARTICLE> 5

<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-1999
<PERIOD-END>                               SEP-30-1999
<CASH>                                             812
<SECURITIES>                                         0
<RECEIVABLES>                                        0
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                                   812
<PP&E>                                               0
<DEPRECIATION>                                       0
<TOTAL-ASSETS>                                     812
<CURRENT-LIABILITIES>                        1,359,073
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                     2,732,908
<OTHER-SE>                                 (4,099,504)
<TOTAL-LIABILITY-AND-EQUITY>                       812
<SALES>                                              0
<TOTAL-REVENUES>                                     0
<CGS>                                                0
<TOTAL-COSTS>                                  160,266
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                              (160,266)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                                  0
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                 (160,266)
<EPS-BASIC>                                     (0.00)
<EPS-DILUTED>                                   (0.00)


</TABLE>
<PAGE>   1
                                                                    EXHIBIT 11.1



                    COMPUTATION OF EARNINGS (LOSS) PER SHARE




<TABLE>
<CAPTION>
                                       Three months ended          Nine months ended
                                          September 30,              September 30,
                                    ------------------------    ------------------------
                                       1998          1997          1998          1997
                                    ----------    ----------    ----------    ----------
<S>                                 <C>           <C>           <C>           <C>
PRIMARY AND FULLY DILUTED:

Average shares outstanding          15,767,220    14,338,929    15,767,220    14,338,929

Dilutive stock equivalents                                       1,044,917
                                    ----------    ----------    ----------    ----------

Total                               15,767,220    14,338,929    16,812,137    14,338,929
                                    ==========    ==========    ==========    ==========

Net Earnings (Loss)                 $  (11,545)   $  (67,520)   $   94,148    $  (55,631)
                                    ==========    ==========    ==========    ==========

Net Earnings (loss) per share       $    (.001)   $    (.005)   $     .006    $    (.004)
                                    ==========    ==========    ==========    ==========

</TABLE>